143 related articles for article (PubMed ID: 12941040)
21. Impaired thrombin generation in Reelin-deficient mice: a potential role of plasma Reelin in hemostasis.
Tseng WL; Chen TH; Huang CC; Huang YH; Yeh CF; Tsai HJ; Lee HY; Kao CY; Lin SW; Liao HR; Cheng JC; Tseng CP
J Thromb Haemost; 2014 Dec; 12(12):2054-64. PubMed ID: 25255925
[TBL] [Abstract][Full Text] [Related]
22. A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.
Matsumoto T; Nogami K; Ogiwara K; Shima M
Int J Hematol; 2009 Dec; 90(5):576-582. PubMed ID: 19937483
[TBL] [Abstract][Full Text] [Related]
23. Evolving techniques for monitoring clotting in plasma and whole blood samples.
Carr ME; Martin EJ
Clin Lab; 2004; 50(9-10):539-49. PubMed ID: 15481629
[TBL] [Abstract][Full Text] [Related]
24. Blood coagulation in hemophilia A and hemophilia C.
Cawthern KM; van 't Veer C; Lock JB; DiLorenzo ME; Branda RF; Mann KG
Blood; 1998 Jun; 91(12):4581-92. PubMed ID: 9616154
[TBL] [Abstract][Full Text] [Related]
25. Thrombin generation test as a marker for high risk venous thrombosis pregnancies.
Joly BS; Sudrié-Arnaud B; Barbay V; Borg JY; Le Cam Duchez V
J Thromb Thrombolysis; 2018 Jan; 45(1):114-121. PubMed ID: 29032523
[TBL] [Abstract][Full Text] [Related]
26. Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma.
Siegemund T; Petros S; Siegemund A; Scholz U; Engelmann L
Thromb Haemost; 2003 Nov; 90(5):781-6. PubMed ID: 14597971
[TBL] [Abstract][Full Text] [Related]
27. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
Shuman MA; Levine SP
J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
[TBL] [Abstract][Full Text] [Related]
28. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor.
Waters EK; Genga RM; Schwartz MC; Nelson JA; Schaub RG; Olson KA; Kurz JC; McGinness KE
Blood; 2011 May; 117(20):5514-22. PubMed ID: 21389323
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B.
Dargaud Y; Béguin S; Lienhart A; Al Dieri R; Trzeciak C; Bordet JC; Hemker HC; Negrier C
Thromb Haemost; 2005 Mar; 93(3):475-80. PubMed ID: 15735797
[TBL] [Abstract][Full Text] [Related]
30. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.
Tanaka KA; Szlam F; Sun HY; Taketomi T; Levy JH
Anesth Analg; 2007 Oct; 105(4):933-9, table of contents. PubMed ID: 17898368
[TBL] [Abstract][Full Text] [Related]
31. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Bottasso B; Simoni L; Rosenberg RD
Blood; 1990 Dec; 76(12):2540-5. PubMed ID: 2265248
[TBL] [Abstract][Full Text] [Related]
32. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
[TBL] [Abstract][Full Text] [Related]
33. Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma.
Woodle SA; Shibeko AM; Lee TK; Ovanesov MV
Thromb Res; 2013 Sep; 132(3):374-80. PubMed ID: 23953593
[TBL] [Abstract][Full Text] [Related]
34. Thrombin generation assay as a possible tool for assessment of reduced activity of clotting factors induced by antiphospholipid antibodies and in-vitro evaluation of treatment options.
Livnat T; Zivelin A; Tamarin I; Guetta V; Salomon O
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):661-6. PubMed ID: 19730246
[TBL] [Abstract][Full Text] [Related]
35. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
Chantarangkul V; Clerici M; Bressi C; Giesen PL; Tripodi A
Haematologica; 2003 May; 88(5):547-54. PubMed ID: 12745274
[TBL] [Abstract][Full Text] [Related]
36. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
Hoffman M; Monroe DM; Oliver JA; Roberts HR
Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
[TBL] [Abstract][Full Text] [Related]
37. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with hemophilia A and B.
Hansson KM; Gustafsson D; Skärby T; Frison L; Berntorp E
J Thromb Haemost; 2015 Jul; 13(7):1293-300. PubMed ID: 25944555
[TBL] [Abstract][Full Text] [Related]
38. The role of platelets in blood coagulation--effects of platelet agonists and GPIIb/IIIa inhibitors studied by free oscillation rheometry.
Ramström S; Rånby M; Lindahl TL
Thromb Res; 2002 Jan; 105(2):165-72. PubMed ID: 11958808
[TBL] [Abstract][Full Text] [Related]
39. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity.
Matsumoto T; Nogami K; Shima M
Int J Hematol; 2017 Feb; 105(2):174-183. PubMed ID: 27730530
[TBL] [Abstract][Full Text] [Related]
40. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.
Wegert W; Harder S; Bassus S; Kirchmaier CM
Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
